Join us in-person in Montreal, QC, Canada for ISSCR Annual Meeting 2026. Learn more about our involvement in the event below.
Evotec at ISSCR Annual Meeting 2026
Hosted Sessions
Rethinking Disease Biology Through Human Diversity: hPSC Platforms Transforming Drug Discovery
Date and Time: 8 July 2026, 8.30 AM – 10.00 AM EDT
This session explores how human pluripotent stem cell platforms can be used to incorporate genetic and population diversity directly into early drug discovery. By leveraging diverse hPSC resources, population scale modeling, and functional genomics, the session highlights how disease biology, therapeutic response, and safety risk can be studied in ways that better reflect real world human variation.
Strategies for iPSC-Based Regenerative Therapies - From Single Cells to Organoids
Date and Time: 8 July 2026, 2.15 PM – 3.45 PM EDT
This session will highlight recent advances in the development of iPSC-derived regenerative therapies across three representative clinical indications: hearing loss, diabetes and liver fibrosis. By showcasing diverse therapeutic formats, including well-defined single-cell populations for precise cell replacement, multicellular clusters that capture greater tissue complexity, and organoids designed for functional tissue repair, speakers will discuss strategies for directing iPSCs into specific cell types as well as key translational challenges.
Poster Presentations iPSC Cell Therapy
From the Bench to GMP: Streamlining the Transfer of Cell-Based Human iPSC Processes to Clinical Grade at Evotec's Manufacturing Site
Presenter: Audrey Holtzinger, VP, iPSC Cell Therapy
Poster #: W1181
Poster session: 8 July, 4:00 PM - 5:15 PM
Off-The-Shelf Immune-Shielded iPSC-Derived CAR γδ T Cells to Treat Hepatocellular Carcinoma
Presenter: Audrey Holtzinger, VP, iPSC Cell Therapy
Poster #: F1257
Poster session: 10 July, 4:00 PM - 5:15 PM
Immune-Shielded iPSC-Derived Macrophages As Novel Treatment Approach for Multiple Types of Fibrosis
Presenter: Stefanie Pfaender, Senior Research Scientist, iPSC Cell Therapy
Poster #: F1404
Poster session: 10 July, 5:15 PM - 6:30 PM
GMP-Compatible Engineering of iPSC-Derived Islet-Like Clusters With A Combined Enhanced Immune-Shielding and Kill-Switch Strategy for Cell Therapy of Type 1 Diabetes
Presenter: Audrey Holtzinger, VP, iPSC Cell Therapy
Poster #: F1258
Poster session: 10 July, 5:15 PM - 6:30 PM
Poster Presentations iPSC Drug Discovery
Modulating Human Reactive Astrocytes in Alzheimer's Disease
Presenter: Bastian Zimmer, VP, iPSC Drug Discovery
Poster #: T1225
Poster session: 9 July, 4:00 PM - 5:15 PM
Modeling and Reversing Alzheimer's-Associated Microglial States Using iPSC-Derived Cells and Disease-Linked Gene Signatures
Presenter: Isabelle Meyer, Research Associate, iPSC Drug Discovery
Poster #: F1019
Poster session: 10 July, 4:00 PM - 5:15 PM
